AIM: Hearing preservation is one of the major goals of acoustic neuroma surgery. In NF-2 patients, bilateral hearing loss is frequently caused by the disease or results from its treatment. Several implant devices for electrical stimulation of the cochlear nucleus have been developed to restore serviceable hearing in these patients. We report our experience and results using a high rate continuous interleaved sampling (CIS) auditory brainstem implant (ABI). METHODS: Between June 1997 and May 2004, 24 NF-2 patients were managed by our group. In 20 patients an ABI was implanted successfully. The cochlear nucleus was located using anatomical landmarks and E-ABR recordings after resection of the neuroma via a retrosigmoid approach in the semi-sitting position. The 12-channel stimulating electrode array was inserted and fixed in the lateral recess. There were no surgical complications related to implantation apart from pseudomeningo that were managed by lumbar drainage. RESULTS: In one patient the electrode array became dislocated and this necessitated revision surgery which was successful. One patient failed to gain benefit from the implant. Overall, 70% of electrodes were found to be serviceable for auditory stimulation, 5.3% of electrodes were primarily nonauditory, and in 7.8% side effects during stimulation were observed. Lip reading was improved by more than 100% as a result of the additional auditory input. For many patients, comprehension of open speech was restored to a useful level. Almost all patients were able to perceive environmental sounds and tinnitus was masked. CONCLUSIONS: Restoration of hearing using ABIs in NF-2 patients is a safe and promising procedure for those who would otherwise be totally deaf. The high rate CIS speech processing strategy has proven to be very useful and effective in direct cochlear nucleus stimulation.
AIM: Hearing preservation is one of the major goals of acoustic neuroma surgery. In NF-2patients, bilateral hearing loss is frequently caused by the disease or results from its treatment. Several implant devices for electrical stimulation of the cochlear nucleus have been developed to restore serviceable hearing in these patients. We report our experience and results using a high rate continuous interleaved sampling (CIS) auditory brainstem implant (ABI). METHODS: Between June 1997 and May 2004, 24 NF-2patients were managed by our group. In 20 patients an ABI was implanted successfully. The cochlear nucleus was located using anatomical landmarks and E-ABR recordings after resection of the neuroma via a retrosigmoid approach in the semi-sitting position. The 12-channel stimulating electrode array was inserted and fixed in the lateral recess. There were no surgical complications related to implantation apart from pseudomeningo that were managed by lumbar drainage. RESULTS: In one patient the electrode array became dislocated and this necessitated revision surgery which was successful. One patient failed to gain benefit from the implant. Overall, 70% of electrodes were found to be serviceable for auditory stimulation, 5.3% of electrodes were primarily nonauditory, and in 7.8% side effects during stimulation were observed. Lip reading was improved by more than 100% as a result of the additional auditory input. For many patients, comprehension of open speech was restored to a useful level. Almost all patients were able to perceive environmental sounds and tinnitus was masked. CONCLUSIONS: Restoration of hearing using ABIs in NF-2patients is a safe and promising procedure for those who would otherwise be totally deaf. The high rate CIS speech processing strategy has proven to be very useful and effective in direct cochlear nucleus stimulation.
Authors: J Kiefer; J Müller; T Pfennigdorff; F Schön; J Helms; C von Ilberg; W Baumgartner; W Gstöttner; K Ehrenberger; W Arnold; K Stephan; W Thumfart; S Baur Journal: ORL J Otorhinolaryngol Relat Spec Date: 1996 May-Jun Impact factor: 1.538
Authors: R Laszig; N Marangos; P Sollmann; R Ramsden; B Fraysse; T Lenarz; H Rask-Andersen; G Bredberg; O Sterkers; M Manrique; B Nevison Journal: Am J Otol Date: 1997-11
Authors: J Helms; J Müller; F Schön; L Moser; W Arnold; T Janssen; R Ramsden; C von Ilberg; J Kiefer; T Pfennigdorf; W Gstöttner; W Baumgartner; K Ehrenberger; H Skarzynski; O Ribari; W Thumfart; K Stephan; W Mann; M Heinemann; P Zorowka; K L Lippert; H P Zenner; M Bohndord; K Hüttenbrink; I Hochmair-Desoyer Journal: ORL J Otorhinolaryngol Relat Spec Date: 1997 Jan-Feb Impact factor: 1.538
Authors: D E Brackmann; W E Hitselberger; R A Nelson; J Moore; M D Waring; F Portillo; R V Shannon; F F Telischi Journal: Otolaryngol Head Neck Surg Date: 1993-06 Impact factor: 3.497
Authors: Matthew D Johnson; Hubert H Lim; Theoden I Netoff; Allison T Connolly; Nessa Johnson; Abhrajeet Roy; Abbey Holt; Kelvin O Lim; James R Carey; Jerrold L Vitek; Bin He Journal: IEEE Trans Biomed Eng Date: 2013-02-01 Impact factor: 4.538
Authors: Minke J C van den Berge; J M C van Dijk; Jan D M Metzemaekers; Bert Maat; Rolien H Free; Pim van Dijk Journal: BMJ Open Date: 2019-06-14 Impact factor: 2.692